Recommendations
Truist Securities Maintains Dave & Buster`s Entertainment (PLAY) Buy Recommendation
Fintel reports that on September 7, 2023, Truist Securities maintained coverage of Dave & Buster`s Entertainment (NASDAQ:PLAY) with a Buy recommendation.
Cantor Fitzgerald Initiates Coverage of Atossa Therapeutics (ATOS) with Overweight Recommendation
Fintel reports that on September 8, 2023, Cantor Fitzgerald initiated coverage of Atossa Therapeutics (NASDAQ:ATOS) with a Overweight recommendation. Analyst Price Forecast Suggests 620.24% Upside
RBC Capital Markets Reiterates Ashtead Group (LSE:AHT) Outperform Recommendation
Fintel reports that on September 7, 2023, RBC Capital Markets reiterated coverage of Ashtead Group (LSE:AHT) with a Outperform recommendation. Analyst Price Forecast Suggests 26.16% Upside
Cantor Fitzgerald Reiterates Aziyo Biologics Inc - (AZYO) Overweight Recommendation
Fintel reports that on September 7, 2023, Cantor Fitzgerald reiterated coverage of Aziyo Biologics Inc - (NASDAQ:AZYO) with a Overweight recommendation.
Goldman Sachs Initiates Coverage of Arch Capital Group (ACGL) with Neutral Recommendation
Fintel reports that on September 8, 2023, Goldman Sachs initiated coverage of Arch Capital Group (NASDAQ:ACGL) with a Neutral recommendation.
Cantor Fitzgerald Reiterates Ascendis Pharma A (ASND) Overweight Recommendation
Fintel reports that on September 7, 2023, Cantor Fitzgerald reiterated coverage of Ascendis Pharma A (NASDAQ:ASND) with a Overweight recommendation.
Cantor Fitzgerald Reiterates SELLAS Life Sciences Group (SLS) Overweight Recommendation
Fintel reports that on September 7, 2023, Cantor Fitzgerald reiterated coverage of SELLAS Life Sciences Group (NASDAQ:SLS) with a Overweight recommendation.
JP Morgan Cazenove Reiterates Barclays (LSE:BARC) Overweight Recommendation
Fintel reports that on September 7, 2023, JP Morgan Cazenove reiterated coverage of Barclays (LSE:BARC) with a Overweight recommendation. Analyst Price Forecast Suggests 63.49% Upside
Evercore ISI Group Maintains Vertiv Holdings Co - (VRT) Outperform Recommendation
Fintel reports that on September 7, 2023, Evercore ISI Group maintained coverage of Vertiv Holdings Co - (NYSE:VRT) with a Outperform recommendation.
Cantor Fitzgerald Reiterates Alx Oncology Holdings (ALXO) Overweight Recommendation
Fintel reports that on September 7, 2023, Cantor Fitzgerald reiterated coverage of Alx Oncology Holdings (NASDAQ:ALXO) with a Overweight recommendation.
Telsey Advisory Group Maintains G-III Apparel Group (GIII) Market Perform Recommendation
Fintel reports that on September 8, 2023, Telsey Advisory Group maintained coverage of G-III Apparel Group (NASDAQ:GIII) with a Market Perform recommendation.
Goldman Sachs Initiates Coverage of Axis Capital Holdings (AXS) with Sell Recommendation
Fintel reports that on September 8, 2023, Goldman Sachs initiated coverage of Axis Capital Holdings (NYSE:AXS) with a Sell recommendation.
Goldman Sachs Initiates Coverage of RenaissanceRe Holdings (RNR) with Buy Recommendation
Fintel reports that on September 8, 2023, Goldman Sachs initiated coverage of RenaissanceRe Holdings (NYSE:RNR) with a Buy recommendation.
HC Wainwright & Co. Reiterates Actinium Pharmaceuticals (ATNM) Buy Recommendation
Fintel reports that on September 7, 2023, HC Wainwright & Co. reiterated coverage of Actinium Pharmaceuticals (AMEX:ATNM) with a Buy recommendation. Analyst Price Forecast Suggests 397.33% Upside
Cantor Fitzgerald Reiterates Bicycle Therapeutics Plc - ADR (BCYC) Overweight Recommendation
Fintel reports that on September 7, 2023, Cantor Fitzgerald reiterated coverage of Bicycle Therapeutics Plc - ADR (NASDAQ:BCYC) with a Overweight recommendation.
Berenberg Initiates Coverage of Harmony Biosciences Holdings (HRMY) with Buy Recommendation
Fintel reports that on September 7, 2023, Berenberg initiated coverage of Harmony Biosciences Holdings (NASDAQ:HRMY) with a Buy recommendation.
Cantor Fitzgerald Reiterates Vaxart (VXRT) Overweight Recommendation
Fintel reports that on September 7, 2023, Cantor Fitzgerald reiterated coverage of Vaxart (NASDAQ:VXRT) with a Overweight recommendation. Analyst Price Forecast Suggests 523.64% Upside
B. Riley Securities Maintains Sportsman`s Warehouse Holdings (SPWH) Buy Recommendation
Fintel reports that on September 7, 2023, B. Riley Securities maintained coverage of Sportsman`s Warehouse Holdings (NASDAQ:SPWH) with a Buy recommendation.